[Pharmacogenetic studies: evaluation guidelines for research ethics committees. Study protocol and patient information sheet (II)].

MLA

Rodríguez-Villanueva, Julio, et al. “[Pharmacogenetic Studies: Evaluation Guidelines for Research Ethics Committees. Study Protocol and Patient Information Sheet (II)].” Medicina Clinica, vol. 120, no. 3, Feb. 2003, pp. 101–07. EBSCOhost, https://doi.org/10.1016/s0025-7753(03)73615-x.

APA

Rodríguez-Villanueva, J., Alsar, M. J., Avendaño, C., Gómez-Piqueras, C., & García-Alonso, F. (2003). [Pharmacogenetic studies: evaluation guidelines for research ethics committees. Study protocol and patient information sheet (II)]. Medicina Clinica, 120(3), 101–107. https://doi.org/10.1016/s0025-7753(03)73615-x

Chicago

Rodríguez-Villanueva, Julio, M Jesús Alsar, Cristina Avendaño, Cristina Gómez-Piqueras, and Fernando García-Alonso. 2003. “[Pharmacogenetic Studies: Evaluation Guidelines for Research Ethics Committees. Study Protocol and Patient Information Sheet (II)].” Medicina Clinica 120 (3): 101–7. doi:10.1016/s0025-7753(03)73615-x.